Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
European Urology
|
September 18, 2017
Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer
Bernadett Szabados, Nick van Dijk, Yen Zhi Tang, et al.
Frontiers in Surgery
|
April 25, 2022
Surgical Correction of Carcinoid Heart Disease Improves Liver Function and 5-Hydroxyindoleacetic Acid Levels
Husnain Abbas Shah, Vandana Sagar, Simon Hughes, et al.
BJUI Compass
|
November 14, 2024
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
Liam Mannion, Verity Watson, Vinod Mullassery, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 25, 2019
The management impact of <sup>68</sup>gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (<sup>68</sup>Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer
Meghana Kulkarni, Simon Hughes, Andrew Mallia, et al.
Nature Methods
|
March 3, 2009
Nanoscale live-cell imaging using hopping probe ion conductance microscopy
Pavel Novak, Chao Li, Andrew I Shevchuk, et al.
BMJ Open
|
September 28, 2019
Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer
Harriet Wylie, Fidelma Cahill, Aida Santaolalla, et al.
European Urology
|
February 5, 2019
Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method
Agustina Bessa, Steven Maclennan, Deborah Enting, et al.
BJU International
|
July 1, 2025
Artificial intelligence-driven streamlining of prostate cancer multidisciplinary team recommendations in a tertiary NHS centre in the UK
Ahmed Khattak, Danny Ruta, Vivek Patkar, et al.
BMC Cancer
|
September 26, 2020
Cohort profile: King's Health Partners bladder cancer biobank
Pinky Kotecha, Charlotte L Moss, Deborah Enting, et al.
BMC Cancer
|
May 24, 2017
Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform
Agus Darwanto, Anne-Mette Hein, Sascha Strauss, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
European Urology
|
September 18, 2017
Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer
Bernadett Szabados, Nick van Dijk, Yen Zhi Tang, et al.
Frontiers in Surgery
|
April 25, 2022
Surgical Correction of Carcinoid Heart Disease Improves Liver Function and 5-Hydroxyindoleacetic Acid Levels
Husnain Abbas Shah, Vandana Sagar, Simon Hughes, et al.
BJUI Compass
|
November 14, 2024
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
Liam Mannion, Verity Watson, Vinod Mullassery, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 25, 2019
The management impact of <sup>68</sup>gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (<sup>68</sup>Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer
Meghana Kulkarni, Simon Hughes, Andrew Mallia, et al.
Nature Methods
|
March 3, 2009
Nanoscale live-cell imaging using hopping probe ion conductance microscopy
Pavel Novak, Chao Li, Andrew I Shevchuk, et al.
BMJ Open
|
September 28, 2019
Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer
Harriet Wylie, Fidelma Cahill, Aida Santaolalla, et al.
European Urology
|
February 5, 2019
Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method
Agustina Bessa, Steven Maclennan, Deborah Enting, et al.
BJU International
|
July 1, 2025
Artificial intelligence-driven streamlining of prostate cancer multidisciplinary team recommendations in a tertiary NHS centre in the UK
Ahmed Khattak, Danny Ruta, Vivek Patkar, et al.
BMC Cancer
|
September 26, 2020
Cohort profile: King's Health Partners bladder cancer biobank
Pinky Kotecha, Charlotte L Moss, Deborah Enting, et al.
BMC Cancer
|
May 24, 2017
Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform
Agus Darwanto, Anne-Mette Hein, Sascha Strauss, et al.
Page
of 9